journal article·2025-07

Bioactive glass-induced B cell depletion remodels the osteoimmunological microenvironment to enhance osteogenesis

Yue Chen, Ting Wang, Ziwei Yan, Fanrui Zeng, Yingyi Li, Chen Bao, Hua Wang, Usanee Pantulap, Aldo R. Boccaccini, Kai Zheng, Wen Sun

Acta Biomaterialia· Volume 201
Publisher page

Abstract

B cells are critical in bone homeostasis, and their dysfunction is linked to various bone disorders. Bioactive glasses (BGs) are known for their immunomodulatory properties and are increasingly utilized in bone regeneration. However, the specific effects of BGs on B cells and their subsequent impact on osteogenesis remain unclear. In this study, we investigated the immunomodulatory effects of three BGs (45S5-BG, 13-93-BG, and B3-Cu-Zn-BG) on B cells. 13-93-BG had minimal effect on the survival of activated B cells, while 45S5-BG induced a noticeable cytotoxic effect on B cells. Notably, B3-Cu-Zn-BG exhibited the highest cytotoxicity towards pathogenic B cells, prompting further investigation into its mechanisms. The ionic dissolution products (IDPs) of B3-Cu-Zn-BG exerted concentration- and time-dependent cytotoxicity on B cells by upregulating the expression of genes associated with the mitochondrial apoptosis pathway and NADPH oxidases. B3-Cu-Zn-BG-derived IDPs elevated reactive oxygen species production in B cells, which induced apoptosis in a concentration-dependent manner. Additionally, when co-cultured with bone marrow stem cells (BMSCs), B3-Cu-Zn-BG-derived IDPs promoted osteoblastic differentiation of BMSCs while selectively targeting and eliminating B cells. To confirm the in vivo osteoimmunomodulatory effects of B3-Cu-Zn-BG-derived IDPs, we employed a human tumor necrosis factor transgenic (TNF-tg) mouse model of rheumatoid arthritis. Intra-articular injection of the IDPs in TNF-tg arthritic mice attenuated bone erosion by reducing B cell aggregates and improving osteoblastic differentiation. This study indicates that B3-Cu-Zn-BG not only induces B cell apoptosis but also promotes osteogenesis, highlighting its potential as a therapeutic strategy for inflammatory bone diseases. STATEMENT OF SIGNIFICANCE: Despite decades of use in tissue regeneration, bioactive glasses (BGs) have not been thoroughly evaluated for their immunomodulatory effects. B cells play a crucial role in the pathogenesis of numerous inflammatory bone diseases. By investigating the immunomodulatory properties of B3-Cu-Zn-BG, this research reveals its ability to selectively induce B cell apoptosis and promote osteoblastic differentiation of bone marrow stem cells. Notably, in a rheumatoid arthritis mouse model, B3-Cu-Zn-BG significantly reduced bone erosion and enhanced osteogenesis. BGs of specific compositions have thus great potential in regulating the osteoimmunology microenvironment by locally modulating B cells. These findings underscore the potential of BGs as a novel therapeutic approach for inflammatory bone diseases, offering insights into bone regeneration and immunomodulation.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Bone and Dental Protein Studies · Dental materials and restorations

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (61)

Show source-provided references
1. Distinct stromal and immune cell interactions shape the pathogenesis of rheumatoid and psoriatic arthritis10.1136/annrheumdis-2021-221761 ↗
2. Interactions of B-lymphocytes and bone cells in health and disease10.1016/j.bone.2021.116296 ↗
3. Antibodies, and more10.2215/CJN.09430915 ↗
4. Microenvironmental niches in the bone marrow required for B-cell development10.1038/nri1780 ↗
5. How B cells influence bone biology in health and disease10.1016/j.bone.2010.06.011 ↗
6. Production of RANKL by memory B cells: a link between B cells and bone erosion in rheumatoid arthritis10.1002/art.39489 ↗
7. Effects of inflammatory and anti-inflammatory cytokines on the bone10.1111/j.1365-2362.2011.02545.x ↗
8. B cells inhibit bone formation in rheumatoid arthritis by suppressing osteoblast differentiation10.1038/s41467-018-07626-8 ↗
9. B-cell-derived TGF-beta1 inhibits osteogenesis and contributes to bone loss in periodontitis10.1177/00220345231161005 ↗
10. Single-cell RNA sequencing in orthopedic research10.1038/s41413-023-00245-0 ↗
11. Regenerating bone with bioactive glass scaffolds: a review of in vivo studies in bone defect models10.1016/j.actbio.2017.08.030 ↗
12. Review of bioactive glass: from Hench to hybrids10.1016/j.actbio.2012.08.023 ↗
13. Bio-inspired multifunctional collagen/electrospun bioactive glass membranes for bone tissue engineering applications10.1016/j.msec.2020.111856 ↗
14. Inflammation and biomaterials: role of the immune response in bone regeneration by inorganic scaffolds10.1039/D0TB01379J ↗
15. Immunomodulatory bioactive glasses for tissue regeneration10.1016/j.actbio.2021.08.023 ↗
16. Modulation of macrophages by bioactive glass/sodium alginate hydrogel is crucial in skin regeneration enhancement10.1016/j.biomaterials.2020.120216 ↗
17. Crystallization study of sol–gel derived 13-93 bioactive glass powder10.1016/j.jeurceramsoc.2020.09.052 ↗
18. Boron substitution in silicate bioactive glass scaffolds to enhance bone differentiation and regeneration10.1016/j.actbio.2024.07.053 ↗
19. Cu, Zn doped borate bioactive glasses: antibacterial efficacy and dose-dependent in vitro modulation of murine dendritic cells10.1039/C9BM01691K ↗
20. Bioactive glasses: from parent 45S5 composition to scaffold-assisted T issue-healing therapies10.3390/jfb9010024 ↗
21. Harnessing biomaterials for immunomodulatory-driven tissue engineering10.1007/s40883-022-00279-6 ↗
22. Using copper-doped mesoporous bioactive glass nanospheres to impart an ti-bacterial properties to dental composites10.3390/pharmaceutics14102241 ↗
23. Adenovirus-based overexpression of tissue inhibitor of metalloproteinases 1 reduces tissue damage in the joints of tumor necrosis factor alpha transgenic mice10.1002/1529-0131(200112)44:12<2888::AID-ART477>3.0.CO;2-3 ↗
24. Galectin-8 involves in arthritic condylar bone loss via podoplanin/AKT /ERK axis-mediated inflammatory lymphangiogenesis10.1016/j.joca.2023.01.008 ↗
25. Dissolution of borate and borosilicate bioactive glasses and the influ ence of ion (Zn, Cu) doping in different solutions10.1016/j.jnoncrysol.2018.08.037 ↗
26. In vitro degradation and conversion of melt-derived microfibrou s borate (13-93B3) bioactive glass doped with metal ions10.1111/jace.13207 ↗
27. Selective and caspase-independent cytotoxicity of bioactive glasses towards giant cell tumor of bone derived neoplastic stromal cells but not to bone marrow derived stromal cells10.1016/j.biomaterials.2021.120977 ↗
28. Osteogenic and anti-tumor Cu and Mn-doped borosilicate nanoparticles for syncretic bone repair and chemodynamic therapy in bone tumor treatment
29. Bioactive glass selectively promotes cytotoxicity towards giant cell tumor of bone derived neoplastic stromal cells and induces MAPK signalling dependent autophagy
30. Dynamic regulation of hypoxia-inducible factor-1alpha activity is essential for normal B cell development10.1038/s41590-020-0772-8 ↗
31. Copper induces cell death by targeting lipoylated TCA cycle proteins10.1126/science.abf0529 ↗
32. Structure and mechanisms of ROS generation by NADPH oxidases10.1016/j.sbi.2019.03.001 ↗
33. NADPH oxidase activation regulates apoptotic neutrophil clearance by murine macrophages10.1182/blood-2017-09-809004 ↗
34. ROS-dependent SOCS3 upregulation disrupts regulatory T cell stability during autoimmune disease development10.1016/j.redox.2025.103590 ↗
35. The pentose phosphate pathway controls oxidative protein folding and prevents ferroptosis in chondrocytes10.1038/s42255-024-01187-5 ↗
36. Dose metric considerations in in vitro assays to improve quantitative in vitro-in vivo dose extrapolations10.1016/j.tox.2013.08.012 ↗
37. Engineering immunomodulatory biomaterials to tune the inflammatory10.1016/j.tibtech.2016.03.009 ↗
38. Nano-bioglass: a versatile antidote for bone tissue engineering problems10.1016/j.proeng.2013.08.288 ↗
39. Nano-bioglass: a versatile antidote for bone tissue engineering proble ms10.1016/j.proeng.2013.08.288 ↗
40. An introduction to biomaterial-based strategies for curbing autoimmunity10.1177/1535370216650294 ↗
41. B cell depletion therapies in autoimmune disease: advances and mechani stic insights10.1038/s41573-020-00092-2 ↗
42. Mechanisms of central tolerance for B cells10.1038/nri.2017.19 ↗
43. B cell-mediated autoimmune diseases10.1007/978-981-15-3532-1_11 ↗
44. Engineering immunomodulatory biomaterials for type 1 diabetes10.1038/s41578-019-0112-5 ↗
45. Biomaterial engineering strategies for B cell immunity modulations10.1039/D3BM01841E ↗
46. Exploiting CD22 to selectively tolerize autoantibody producing B-cells in rheumatoid arthritis10.1021/acschembio.8b01018 ↗
47. Bioactive glasses entering the mainstream10.1016/j.drudis.2018.05.027 ↗
48. Biomolecule and ion releasing mesoporous nanoparticles: nonconvergent osteogenic and osteo-immunogenic performance10.1021/acsami.4c17540 ↗
49. Ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics
50. Impact of fluid flow rate on the dissolution behavior of bioactive gla ss S53P410.1016/j.jnoncrysol.2023.122219 ↗
51. Dissolution of glass–Ceramic scaffolds of bioactive glasses 45S5 and S 53P4
52. Porous and strong bioactive glass (13-93) scaffolds prepared by unidirectional freezing of camphene-based suspensions10.1016/j.actbio.2011.07.034 ↗
53. Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-kappaB signaling10.1007/s10787-017-0309-4 ↗
54. Biocomposites of copper-containing mesoporous bioactive glass and nanofibrillated cellulose: biocompatibility and angiogenic promotion in chronic wound healing application10.1016/j.actbio.2016.09.021 ↗
55. Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes10.1016/j.tibs.2010.04.002 ↗
56. Oxidative stress-initiated one-carbon metabolism drives the generation of interleukin-10-producing B cells to resolve pneumonia10.1038/s41423-023-01109-7 ↗
57. Selenium-doped mesoporous bioactive glass regulates macrophage metabolism and polarization by scavenging ROS and promotes bone regeneration In vivo10.1021/acsami.3c03446 ↗
58. New insights into the role of mitochondrial dynamics in oxidative stress-induced diseases
59. The rheumatoid arthritis drug Auranofin targets peroxiredoxin 1 and peroxiredoxin 2 to trigger ROS-endoplasmic reticulum stress axis-mediated cell death and cytoprotective autophagy10.1016/j.freeradbiomed.2025.03.016 ↗
60. Unraveling the immunomodulatory and metabolic effects of bioactive glass S53P4 on macrophages in vitro10.1007/s10856-025-06861-y ↗
61. Inorganic biomaterials for regenerative medicine10.1021/acsami.9b17801 ↗